{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:31:54Z","timestamp":1762432314262,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.toxicon.2023.107096","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T21:39:19Z","timestamp":1679607559000},"page":"107096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy and safety of two different botulinum toxin type A dilutions in chronic migraineurs"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4200-761X","authenticated-orcid":false,"given":"Yan","family":"Tereshko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lettieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Belgrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2023.107096_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/09540261.2017.1326882","article-title":"Depression comorbidity in migraine","volume":"29","author":"Amoozegar","year":"2017","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.toxicon.2023.107096_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10194-010-0282-4","article-title":"Migraine and psychiatric comorbidity: a review of clinical findings","volume":"12","author":"Antonaci","year":"2011","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.toxicon.2023.107096_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jpsychires.2015.02.025","article-title":"Reduced default mode network suppression during a working memory task in remitted major depression","volume":"64","author":"Bartova","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2023.107096_bib4","first-page":"S61","article-title":"Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications","volume":"30","author":"Baskin","year":"2009","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.toxicon.2023.107096_bib5","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/head.13823","article-title":"Modifications to the PREEMPT protocol for OnabotulinumtoxinA injections for chronic migraine in clinical practice","volume":"60","author":"Begasse de Dhaem","year":"2020","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib7","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1526-4610.2010.01766.x","article-title":"Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program","volume":"50","author":"Blumenfeld","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/head.13074","article-title":"Insights into the functional anatomy behind the PREEMPT injection paradigm: guidance on achieving optimal outcomes","volume":"57","author":"Blumenfeld","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib9","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.35190","article-title":"Current understanding on pain mechanism in migraine and cluster headache","volume":"6","author":"Buture","year":"2016","journal-title":"Anesthesiol. Pain Med."},{"key":"10.1016\/j.toxicon.2023.107096_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5603\/PJNNS.a2021.0027","article-title":"Botulinum toxin type-A preparations are not the same medications - basic science (Part 1)","volume":"55","author":"Car","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5TM","key":"10.1016\/j.toxicon.2023.107096_bib11"},{"key":"10.1016\/j.toxicon.2023.107096_bib12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ene.13523","article-title":"OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study","volume":"25","author":"Dom\u00ednguez","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2023.107096_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13104-017-2484-1","article-title":"Spontaneous migraine attack causes alterations in default mode network connectivity: a resting-state fMRI case report","volume":"10","author":"Edes","year":"2017","journal-title":"BMC Res. Notes"},{"first-page":"1","year":"2018","series-title":"The International Classification of Headache Disorders","key":"10.1016\/j.toxicon.2023.107096_bib15"},{"key":"10.1016\/j.toxicon.2023.107096_bib16","article-title":"Is there an association between migraine and major depressive disorder? A narrative review","volume":"12","author":"Jahangir","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.toxicon.2023.107096_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1526-4610.2007.00993.x","article-title":"Comorbidity of migraine and psychiatric disorders--a national population-based study","volume":"48","author":"Jette","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s10194-021-01260-4","article-title":"Real-life use of onabotulinumtoxinA reduces healthcare resource utilization in individuals with chronic migraine: the REPOSE study","volume":"22","author":"Kollewe","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.toxicon.2023.107096_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neulet.2016.06.001","article-title":"In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA","volume":"627","author":"Kutschenko","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxicon.2023.107096_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcma.2013.09.006","article-title":"Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: a retrospective study","volume":"77","author":"Lin","year":"2014","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.toxicon.2023.107096_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0306-4522(83)90268-3","article-title":"Pia arachnoid contains substance P originating from trigeminal neurons","volume":"9","author":"Liu-Chen","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxicon.2023.107096_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s10194-018-0876-9","article-title":"Exploration of intrinsic brain activity in migraine with and without comorbid depression","volume":"19","author":"Ma","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.toxicon.2023.107096_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1526-4610.2007.00914.x","article-title":"Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache","volume":"48","author":"Mathew","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2023.107096_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","article-title":"The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation","volume":"19","author":"May","year":"1999","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"10.1016\/j.toxicon.2023.107096_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0733-8619(05)70298-X","article-title":"Comorbidity of migraine and psychiatric disorders","volume":"15","author":"Merikangas","year":"1997","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.toxicon.2023.107096_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","article-title":"Global prevalence of chronic migraine: a systematic review","volume":"30","author":"Natoli","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.toxicon.2023.107096_bib27","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1111\/jocd.14361","article-title":"Botulinum toxin\u2013induced blepharoptosis: anatomy, etiology, prevention, and therapeutic options","volume":"20","author":"Nestor","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2023.107096_bib28","first-page":"241","article-title":"[Predictive factors of the response to treatment with onabotulinumtoxinA in refractory migraine]","volume":"58","author":"Pagola","year":"2014","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.toxicon.2023.107096_bib29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fneur.2019.00678","article-title":"Response predictors in chronic migraine: medication overuse and depressive symptoms negatively impact onabotulinumtoxin-A treatment","volume":"10","author":"Schiano di Cola","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.toxicon.2023.107096_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14060383","article-title":"Treatment of depression with botulinum toxin","volume":"14","author":"Wollmer","year":"2022","journal-title":"Toxins"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012300082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012300082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:22:48Z","timestamp":1758576168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101012300082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"alternative-id":["S004101012300082X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107096","relation":{},"ISSN":["0041-0101"],"issn-type":[{"type":"print","value":"0041-0101"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of two different botulinum toxin type A dilutions in chronic migraineurs","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2023.107096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107096"}}